{"abstract":"The Food and Drug Administration (FDA) is staying the final monograph for over-the-counter (OTC) sunscreen drug products that published in the Federal Register of May 21, 1999 (64 FR 27666). The final monograph established conditions under which OTC sunscreen drug products are generally recognized as safe and effective and not misbranded. This stay of effective date applies to all OTC sunscreen drug products that would be regulated under part 352 (21 CFR part 352). This action does not stay the effective date for products that would be regulated under parts 310 and 700 (21 CFR parts 310 and 700). This action is being taken because the agency will be amending part 352 to address formulation, labeling, and testing requirements for both ultraviolet A (UVA) radiation protection and ultraviolet B (UVB) radiation protection. This action is part of FDA's ongoing review of OTC drug products.","action":"Final rule; partial stay.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2001/12/31/01-32086.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"352","title":21}],"citation":"66 FR 67485","comment_url":null,"comments_close_on":"2002-04-01","correction_of":null,"corrections":[],"dates":"This rule is effective January 30, 2002. Part 352, added at 64 FR 27666 at 27687, is stayed until further notice. Written or electronic comments by April 1, 2002.","disposition_notes":null,"docket_ids":["Docket No. 78N-0038"],"dockets":[],"document_number":"01-32086","effective_on":"2002-01-30","end_page":67487,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2001/12/31/01-32086.xml","html_url":"https://www.federalregister.gov/documents/2001/12/31/01-32086/sunscreen-drug-products-for-over-the-counter-human-use-final-monograph-partial-stay-final-rule","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/01-32086?publication_date=2001-12-31","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2001-12-31/01-32086/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":484,"last_updated":"2026-11-22 14:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2001-12-31/pdf/01-32086.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2001-12-31","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2001/12/31/01-32086.txt","regulation_id_number_info":{"0910-AA01":{"issue":"200310","html_url":"https://www.federalregister.gov/regulations/0910-AA01/over-the-counter-otc-drug-review","title":"Over-the-Counter (OTC) Drug Review","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=200310&RIN=0910-AA01&operation=OPERATION_EXPORT_XML","priority_category":"Routine and Frequent"}},"regulation_id_numbers":["0910-AA01"],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Reference 208 - Kasichayanula_2005_Simultaneous Analysis of Insect Repellent DEET, Sunscreen Oxybenzone and Five Relevant Metabolites","document_id":"FDA-1978-N-0018-1049"},{"title":"Reference 196 - FDA_Food Additive Status List","document_id":"FDA-1978-N-0018-1037"},{"title":"Reference 193 - Katz_2008_Insect Repellants- Historical Perspectives and New Developments","document_id":"FDA-1978-N-0018-1034"},{"title":"Reference 190 - EPA_Using Insect Repellents Safely and Effectively","document_id":"FDA-1978-N-0018-1031"},{"title":"Reference 180 - TGA_2016_Australian regulatory guidelines for sunscreens","document_id":"FDA-1978-N-0018-1021"},{"title":"Reference 169 - Damian_2011_An action spectrum for UV radiation-induced immunosuppression in humans","document_id":"FDA-1978-N-0018-1010"},{"title":"Reference 153 - Liu_2017_Particle Size Distribution Analysis of OTC Drug Products with Unintended Inhalation Exposure to Consumers","document_id":"FDA-1978-N-0018-0994"},{"title":"Reference 148 - Stuart_1984_Deposition and Clearance of Inhaled Particles","document_id":"FDA-1978-N-0018-0989"},{"title":"Reference 134 - Rodriguez_2006_Causal agents of photoallergic contact dermatitis","document_id":"FDA-1978-N-0018-0975"},{"title":"Reference 99 - Gupta_1999_Percutaneous Absorption of Sunscreens through Micro-Yucatan Pig Skin in Vitro","document_id":"FDA-1978-N-0018-0939"}],"regulatory_plan":{"html_url":"https://www.federalregister.gov/regulations/0910-AF43/sunscreen-drug-products-for-over-the-counter-human-use-final-monograph-","title":"Sunscreen Drug Products For Over-The-Counter-Human Use; Final Monograph\n"},"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-1978-N-0018","supporting_documents_count":325,"docket_id":"FDA-1978-N-0018","regulation_id_number":"0910-AF43","title":"Sunscreen Drug Products -OPEN","checked_regulationsdotgov_at":"2019-07-27T10:00:12Z"},"regulations_dot_gov_url":null,"significant":false,"signing_date":null,"start_page":67485,"subtype":null,"title":"Sunscreen Drug Products for Over-the-Counter Human Use; Final Monograph; Partial Stay; Final Rule","toc_doc":"Sunscreen products (OTC); final monograph; partial stay","toc_subject":"Human drugs:","topics":[],"type":"Rule","volume":66}